“RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: CHEMOIMMUNOTHERAPY, TREATMENT UNTIL PROGRESSION WITH MECHANISM-DRIVEN AGENTS OR FINITE-DURATION THERAPY?” (2019) Mediterranean Journal of Hematology and Infectious Diseases, 11(1), p. e2019024. doi:10.4084/mjhid.2019.024.